Aegerion Pharmaceuticals has been powering higher, and one
investor apparently thinks that the gains will continue.
optionMONSTER's Heat Seeker monitoring program detected the
purchase of 1,250 January 25 calls for $1.15 and the sale of an
equal number of January 30 calls for $0.20. An equal-sized block
was also sold in the December 20 calls for $1.95, but volume was
below open interest in that strike.
The activity suggests that the trader came into the session owning
the lower-strike calls, then closed that position and rolled it to
in the January contracts. He or she collected a net credit of $1
and has the right to earn an additional $5 if the stock goes to $30
or higher on expiration. (See our
AEGR is down 2.44 percent to $21.56 in morning trading. The stock
gapped higher in mid-October after a Food and Drug Administration
advisory panel recommended approval of the company's lomitapide
drug, which is used to treat a genetic disorder that causes high
The shares have been consolidating since that move in October and
making incremental higher lows, which could be leading some chart
watchers to believe that it's still headed higher.
Total option volume is 7 times greater than average, according to
the Heat Seeker. Calls outnumber puts by a bullish 10-to-1
Copyright © 2010 OptionMonster® Holdings, Inc. All Rights Reserved.